Sign in
4/A

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-21-039322

Senior Vice President, Finance sold 22,500 shares at $35.00 ($787,500)

  • Senior Vice President, Finance acquired 22,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Catinazzo Thomas · Senior Vice President, Finance

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-30 Exercise or conversion : show line 1 in the form +22,500 $4.12 $92,700 38,370 D
2021-03-30 Sale : show line 2 in the form −22,500 $35.00 $787,500 15,870 D
Open-market sales · 22,500 sh · avg $35.00 · $787,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-03-30 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −22,500 107,043 D
Loading xslF345X03/doc4a.xml…